¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2032³â)
Cardiac Biomarker Diagnostic Test Kits Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1640824
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 209 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Áö¼Ó¼º ½ÃÀå Á¶»ç´Â ÃÖ±Ù ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå¿¡ ´ëÇÑ Æ÷°ýÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çϰí ÃßÁø ¿äÀÎ, ½ÅÈï µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ ½ÉÃþ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀÌÇØ¸¦ Á¦°øÇÏ¿© ÀÌÇØ°ü°èÀÚ°¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå : ºÐ¼® ¹üÀ§

¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå¿¡´Â ½ÉÀå °ü·Ã ÁúȯÀÇ ÁöÇ¥·Î ÀÛ¿ëÇÏ´Â Ç÷·ùÀÇ Æ¯Á¤ »ýü ºÐÀÚ¸¦ ½Äº°ÇÏ´Â µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¶±â Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä, ¹ÙÀÌ¿À¸¶Ä¿ °ËÃâ ±â¼ú ¹ßÀü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Å×½ºÆ® ŰƮ´Â Æ®·ÎÆ÷´Ñ, Å©·¹¾ÆÆ¾ Ű³ª¾ÆÁ¦-MB(CK-MB), NT-proBNP¿Í °°Àº ÁÖ¿ä ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°ÇÏ¿© ½É±Ù°æ»ö, ½ÉºÎÀü, ½É±Ù ¼Õ»ó°ú °°Àº ½ÉÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ ½ÃÀåÀº °í°¨µµ Áø´Ü ŰƮ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÅëÇÕÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¶ÇÇÑ ½ÉÇ÷°ü °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­, ƯÈ÷ °í·É Àα¸¿Í »ýȰ ½À°ü À§Çè ¿äÀÎÀ» °¡Áø »ç¶÷µé »çÀÌ¿¡¼­ ½ÉÇ÷°ü °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ·¯ÇÑ Áø´Ü ŰƮ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

½ÉÇ÷°ü Áúȯ(CVD)ÀÇ À¯º´·ü Áõ°¡´Â ±Û·Î¹ú ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä µ¿ÀÎ Áß ÇϳªÀÔ´Ï´Ù. ½É±Ù°æ»ö, ½ÉºÎÀü µî ½ÉÀå °ü·Ã ÁúȯÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ´Ã¾î³ª´Â ÀÇ·á ºÎ´ãÀ» ÇØ°áÇϱâ À§ÇÑ È¿°úÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Å×½ºÆ® ŰƮ´Â ½ÉÇ÷°ü ÁúȯÀ» Áø´Ü, ¸ð´ÏÅ͸µ ¹× °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ÀÇ·á Àü¹®°¡°¡ ȯÀÚ Ä¡·á¿Í °ü·ÃÇÏ¿© Àû½Ã¿¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. °í°¨µµ ºÐ¼®, ´ÙÁß ¸é¿ª ºÐ¼®, ÇöÀå °Ë»ç µî ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ °ËÃ⠺оßÀÇ ±â¼ú ¹ßÀüÀº ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº °Ë»çÀÇ Á¤È®¼º, ¼Óµµ, È¿À²¼ºÀ» °³¼±ÇÏ¿© ´õ ³ªÀº ȯÀÚ °á°ú¿Í ±¤¹üÀ§ÇÑ ÀÓ»ó Àû¿ëÀ¸·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× À§Çè °èÃþÈ­ Á¢±Ù¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÇ÷°ü Ä¡·á¿¡¼­ °í±Þ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå ±Ëµµ¿¡µµ ºÒ±¸ÇÏ°í ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀåÀº ¸î °¡Áö µµÀü °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ »õ·Î¿î Áø´Ü ŰƮÀÇ ½ÂÀÎ ¹× »ó¿ëÈ­¿Í °ü·ÃµÈ ±ÔÁ¦ Àå¾Ö¹°Àº ½ÃÀå È®ÀåÀ» ´õµð°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ªº°·Î ´Ù¾çÇÑ ±ÔÁ¦¸¦ ÁؼöÇØ¾ß ÇÏ´Â º¹À⼺À¸·Î ÀÎÇØ ¼Ò±Ô¸ð ±â¾÷Àº ³ôÀº ±ÔÁ¦ Áؼö ºñ¿ëÀ¸·Î ÀÎÇØ È¿°úÀûÀ¸·Î °æÀïÇÏ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀûÀÎ ¹®Á¦µµ ½ÃÀå Âü¿©Àڵ鿡°Ô Á¦¾àÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Áø´Ü ±â¼úÀÇ Çõ½Å ¼Óµµ°¡ »¡¶óÁö¸é¼­ °æÀï ¿ìÀ§¸¦ À¯ÁöÇϱâ À§Çؼ­´Â ¿¬±¸ °³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ±³Â÷ ¹ÝÀÀ¼º, ¿ÀŽ, ÁøÈ­ÇÏ´Â Áø´Ü Ç÷§Æû°úÀÇ È£È¯¼º Çʿ伺°ú °°Àº ¹®Á¦´Â ½ÃÀåÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µì´Ï´Ù.

½ÃÀå ±âȸ

¼¼°èÀÇ ½ÃÀåÀº ÇöÀå Áø´Ü(POC) Å×½ºÆ® ¿ª·®À» È®ÀåÇÏ´Â µ¥ ÀÖ¾î »ó´çÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÀÀ±Þ ȯ°æ°ú ÀÇ·á ¼­ºñ½º°¡ Ãë¾àÇÑ Áö¿ª¿¡¼­ ºü¸£°í ¾ÈÁ¤ÀûÀÌ¸ç »ç¿ëÇϱ⠽¬¿î Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ ÇöÀå Áø·á Å×½ºÆ®¸¦ ÅëÇØ ½Ç½Ã°£ Áø´ÜÀÌ °¡´ÉÇϹǷΠÀÇ»ç °áÁ¤À» ´õ ºü¸£°Ô ³»¸®°í ȯÀÚ Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀ̰í Á¤È®ÇÑ POC ŰƮ¸¦ °³¹ßÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀåÇÏ´Â ÀÌ ºÐ¾ß¸¦ °ø·«ÇÏ¿© Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÇ·á Àü¹®°¡¿¡°Ô Áï°¢ÀûÀÎ ÀÓ»ó ÀÇ»ç°áÁ¤À» À§ÇÑ À¯¿ëÇÑ µµ±¸¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÅëÇÕ°ú ¸ÖƼÇ÷º½º ºÐ¼®ÀÇ ¹ßÀüÀº Å×½ºÆ® ŰƮÀÇ Áø´Ü ±â´ÉÀ» È®ÀåÇÒ ¼ö ÀÖ´Â »ó´çÇÑ ÀáÀç·ÂÀ» Á¦°øÇÕ´Ï´Ù. ´Ù¾çÇÑ ½ÉÇ÷°ü Áúȯ°ú °ü·ÃµÈ »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿°¡ °è¼Ó ¹ß°ßµÊ¿¡ µû¶ó ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀåÀº ´õ¿í Æ÷°ýÀûÀ̰í Á¤È®ÇÑ Áø´Ü ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇϵµ·Ï ÁøÈ­ÇÒ °ÍÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦4Àå ¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : Áö¿ªº°

Á¦5Àå ºÏ¹ÌÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦6Àå À¯·´ÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦7Àå µ¿¾Æ½Ã¾ÆÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦8Àå ³²¾Æ½Ã¾Æ ¿À¼¼¾Æ´Ï¾ÆÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ Áø´Ü ŰƮ ½ÃÀå Àü¸Á : °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the global Cardiac Biomarker Diagnostic Test Kits Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Cardiac Biomarker Diagnostic Test Kits Market - Report Scope:

The global cardiac biomarker diagnostic test kits market includes tools for identifying specific biomolecules in the bloodstream that act as indicators for heart-related conditions. The market is driven by the increasing prevalence of cardiovascular diseases, the demand for early diagnostic solutions, and technological advancements in biomarker detection. These test kits help identify key biomarkers such as troponins, creatine kinase-MB (CK-MB), and NT-proBNP, allowing for the early detection of heart conditions like myocardial infarction, heart failure, and myocardial damage. The market is characterized by a growing demand for high-sensitivity diagnostic kits and the integration of new biomarkers. Additionally, the increasing awareness of cardiovascular health, particularly among aging populations and those with lifestyle risk factors, is expected to drive the demand for these diagnostic test kits.

Market Drivers:

The rising prevalence of cardiovascular diseases (CVDs) is one of the primary drivers of growth in the global cardiac biomarker diagnostic test kits market. As heart-related conditions, such as myocardial infarction and heart failure, continue to increase, effective diagnostic solutions are needed to address the growing healthcare burden. These test kits are crucial for diagnosing, monitoring, and managing cardiovascular diseases, enabling healthcare professionals to make timely and informed decisions regarding patient care. Technological advancements in cardiac biomarker detection, including innovations in high-sensitivity assays, multiplex immunoassays, and point-of-care testing, further contribute to the market's growth. These innovations improve the accuracy, speed, and efficiency of testing, leading to better patient outcomes and broader clinical applications. Additionally, the increasing adoption of personalized medicine and risk stratification approaches further drives the demand for advanced diagnostic tools in cardiovascular care.

Market Restraints:

Despite the promising growth trajectory, the cardiac biomarker diagnostic test kits market faces several challenges. Regulatory hurdles, particularly around the approval and commercialization of new diagnostic kits, may slow down market expansion. The complexity of navigating varying regulations across regions may limit the ability of smaller companies to compete effectively, as they struggle with the high cost of compliance. Technological challenges also pose a restraint for market players. The rapid pace of innovation in diagnostic technologies requires continuous investment in research and development to maintain competitive advantage. Issues such as cross-reactivity, false positives, and the need for compatibility with evolving diagnostic platforms add layers of complexity to the market.

Market Opportunities:

The global market presents significant growth opportunities in expanding point-of-care (POC) testing capabilities. The demand for quick, reliable, and easy-to-use diagnostic solutions is on the rise, particularly in emergency settings and underserved regions. Point-of-care testing for cardiac biomarkers allows for real-time diagnosis, enabling faster decision-making and improving patient care. By developing user-friendly and accurate POC kits, companies can tap into this growing segment, enhancing accessibility and providing healthcare professionals with valuable tools for immediate clinical decision-making. Further, the increasing integration of novel biomarkers and advancements in multiplex assays offer significant potential for expanding the diagnostic capabilities of test kits. As research continues to discover new biomarkers associated with various cardiovascular conditions, the market for cardiac biomarker diagnostic test kits will evolve to include more comprehensive and accurate diagnostic solutions.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading companies in the global cardiac biomarker diagnostic test kits market, including Roche, Abbott Laboratories, and Siemens Healthineers, are focusing on product innovation and expanding their diagnostic portfolios to stay competitive. These companies are investing heavily in the development of high-sensitivity assays, multiplex testing systems, and point-of-care diagnostics. Strategic partnerships and collaborations with research institutions and healthcare providers are also key strategies employed to drive product development and market penetration. In addition to technological advancements, key players are focusing on regulatory compliance to ensure swift market entry of new products. Investment in R&D is critical for staying ahead in this dynamic market, enabling companies to cater to the evolving needs of healthcare professionals and patients worldwide.

Key Companies Profiled:

Cardiac Biomarker Diagnostic Test Kits Market Segmentation:

By Product Type:

By Indication:

By End-use:

By Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

4. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook: Region

5. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

6. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

7. East Asia Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

8. South Asia & Oceania Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

9. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

10. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

11. Competition Landscape

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â